Anne Moscona

Title: The Pioneering Work of Inventor Anne Moscona in Viral Inhibition

Introduction

Anne Moscona, a notable inventor based in New York, NY, has made significant contributions to the field of virology through her innovative research and patented inventions. With two patents to her name, Moscona has focused on developing methods to inhibit viral infections, showcasing her expertise in the biomedical field.

Latest Patents

Moscona's latest patents include groundbreaking inventions aimed at preventing viral infections. One notable patent is for "Inhibitors of fusion between viral and cell membranes as well as compositions and methods of using them." This invention details an inhibitor that targets the fusion of viral and cell membranes, utilizing a C-terminal peptide from a fusion mediating protein of an enveloped virus. The inhibitor is paired with tocopherol or its derivatives, leading to pharmaceutical compositions that can effectively inhibit viral fusion, block viral spread, and treat viral infections.

Another patent she holds is related to an "Anti-viral method," which outlines a novel approach to reducing viral infectivity in a sample. This method involves using a carrier matrix with lipids attached, to which a virus-specific agent binds. The methodology includes inactivating a virus by interacting with its receptors, ultimately leading to the release of the virus from the carrier matrix. These inventions are critical advancements in the fight against viral diseases.

Career Highlights

Throughout her career, Anne Moscona has held notable positions in reputable institutions. She has worked at Cornell University, contributing to academic research and education. Additionally, she has been affiliated with the Institut National De La Santé Et De La Recherche Médicale (INSERM), where she furthered her research in virology and infectious diseases. Her contributions to these institutions underscore her commitment to scientific advancement and innovation.

Collaborations

Anne Moscona has collaborated with several esteemed colleagues, including Matteo Porotto and Branka Horvat. These collaborations have enriched her research, enabling her to work on challenging problems in the field of virology and develop solutions that have real-world applications.

Conclusion

Anne Moscona's work exemplifies the impact of innovative thinking in the realm of virology. With her patents addressing crucial challenges in viral infections, her contributions have the potential to improve treatment options and health outcomes globally. As she continues to advance her research, Moscona remains a significant figure in the landscape of inventors and innovators dedicated to fighting viral diseases.